Learning Objectives:

  1. To establish whether treatment with corticosteroid-cyclophosphamide induced remission of nephrotic syndrome in a significantly greater number of patients than treatment with tacrolimus-rituximab, although side-effects were more frequent in the former group.
  2. To determine clinical significance of study results.
Session date: 
Friday, June 18, 2021 - 12:00pm to 1:00pm
Location: 
Zoom meeting
5700 S. Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sri Mahathi Kalipatnapu, MD